Market Cap for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported market cap is $179.36B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$179.36B
YoY change
-27.1%
5Y CAGR
-8.7%
Peak year (2021)
$251.78B
Latest annual
$159.55B
Market Cap history chart for Abbott Laboratories (ABT) from 1985 to 2026
Market Cap history table for Abbott Laboratories (ABT) from 1985 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $159.55B | -27.1% | ||
| 2025 | $218.88B | +10.7% | ||
| 2024 | $197.72B | +2.7% | ||
| 2023 | $192.51B | -0.6% | ||
| 2022 | $193.67B | -23.1% | ||
| 2021 | $251.78B | +28.8% | ||
| 2020 | $195.55B | +26.4% | ||
| 2019 | $154.70B | +20.8% | ||
| 2018 | $128.02B | +28.3% | ||
| 2017 | $99.82B | +75.2% | ||
| 2016 | $56.96B | -15.8% | ||
| 2015 | $67.63B | -1.6% | ||
| 2014 | $68.75B | +13.9% | ||
| 2013 | $60.33B | +20.9% | ||
| 2012 | $49.89B | +18.1% | ||
| 2011 | $42.24B | +18.4% | ||
| 2010 | $35.66B | -11.2% | ||
| 2009 | $40.17B | +0.8% | ||
| 2008 | $39.85B | -4.9% | ||
| 2007 | $41.90B | +17.0% | ||
| 2006 | $35.81B | +21.4% | ||
| 2005 | $29.50B | -15.9% | ||
| 2004 | $35.06B | +6.5% | ||
| 2003 | $32.93B | +16.4% | ||
| 2002 | $28.29B | -27.9% | ||
| 2001 | $39.26B | +15.1% | ||
| 2000 | $34.10B | +34.1% | ||
| 1999 | $25.44B | -26.0% | ||
| 1998 | $34.39B | +48.3% | ||
| 1997 | $23.19B | +28.5% | ||
| 1996 | $18.05B | +20.9% | ||
| 1995 | $14.93B | +25.3% | ||
| 1994 | $11.91B | +7.8% | ||
| 1993 | $11.04B | -3.4% | ||
| 1992 | $11.44B | -13.1% | ||
| 1991 | $13.17B | +50.9% | ||
| 1990 | $8.73B | +30.2% | ||
| 1989 | $6.70B | +38.7% | ||
| 1988 | $4.83B | -1.3% | ||
| 1987 | $4.90B | +2.7% | ||
| 1986 | $4.77B | +33.5% | ||
| 1985 | $3.57B | — |
Market Cap values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2026, Abbott Laboratories (ABT) market cap totalled $159.55B – declined 27.1% year-over-year.
Looking at the 2021–2026 (5 years) stretch, Abbott Laboratories market cap compounded at -8.7% per year, with a net decline across the window.
Between 2021 and 2026, Abbott Laboratories market cap plunged 36.6%, falling from $251.78B to $159.55B.
The dataset's maximum market cap sits at $251.78B (2021); the minimum reading of $3.57B dates to 1985.
Among 8 Healthcare peers, Abbott Laboratories (ABT) ranks 9th; the peer median for market cap is $311.16B.
Abbott Laboratories Market Cap by Year
Abbott Laboratories Market Cap 2026: $159.55B
Abbott Laboratories market cap in 2026 was $159.55B, declined 27.1% below 2025.
Abbott Laboratories Market Cap 2025: $218.88B
Abbott Laboratories market cap in 2025 was $218.88B, grew 10.7% from 2024.
Abbott Laboratories Market Cap 2024: $197.72B
Abbott Laboratories market cap in 2024 was $197.72B, edged up 2.7% from 2023.
Abbott Laboratories Market Cap 2023: $192.51B
Abbott Laboratories market cap in 2023 was $192.51B, edged down 0.6% below 2022.
Abbott Laboratories Market Cap 2022: $193.67B
Abbott Laboratories market cap in 2022 was $193.67B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Market Cap
Companies in the same sector as Abbott Laboratories, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's market cap?
- Latest reported market cap for Abbott Laboratories (ABT) is $179.36B (period ending March 31, 2026).
How has Abbott Laboratories market cap changed year-over-year?
- Abbott Laboratories (ABT) market cap changed -27.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories market cap?
- Abbott Laboratories (ABT) market cap compound annual growth rate is -8.7% over the most recent 5 years available.
When did Abbott Laboratories market cap hit its highest annual value?
- Abbott Laboratories market cap reached its highest annual value of $251.78B in 2021.
What was Abbott Laboratories market cap in 2025?
- Abbott Laboratories (ABT) market cap in 2025 was $218.88B.
What was Abbott Laboratories market cap in 2026?
- Abbott Laboratories (ABT) market cap in 2026 was $159.55B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.